vendredi 19 juillet 2019
The Michael J. Fox Foundation : Imaging Biomarkers to Track Disease Progression and Therapeutic Efficacy
The Michael J. Fox Foundation will award one- to three-year grants to develop imaging markers for use in disease-modifying clinical trials
Applications must focus on developing robust and precise imaging markers.
• Priority targets for this program are alpha-synuclein and neuroinflammation, but applications may focus on other promising therapeutic targets.
• Imaging modalities can include PET, SPECT and MRI.
• Projects should aim to develop novel imaging biomarkers as opposed to prospectively collecting data using existing technologies. Prospective data collection is appropriate only if a novel imaging technique or tracer is being tested. Novel data analysis techniques may be proposed but should utilize existing data sets.
• Examples of projects that are appropriate for this program include development of novel PET or SPECT tracers, early validation of new tracers, and development and validation of novel MRI techniques.
Pre-Proposals Due: April 19, 2019, 5 p.m. ET
Full Proposal Invitations: Week of June 10, 2019
Full Proposals Due (by invite only): July 19, 2019, 5 p.m. ET
Anticipated Award Announcement: September 2019
Anticipated Funding: October 2019
More information : https://www.michaeljfox.org/research/grant-detail.php?id=41